• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    BeautyHealth Names Michael Monahan Chief Financial Officer

    8/9/23 7:25:00 AM ET
    $SKIN
    $CSPR
    Medical/Dental Instruments
    Health Care
    Diversified Commercial Services
    Miscellaneous
    Get the next $SKIN alert in real time by email

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announces Michael Monahan has been named Chief Financial Officer, effective August 10, 2023. He succeeds Liyuan Woo, who is leaving BeautyHealth but will remain as an advisor until September 1, 2023 to assist with the transition.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230809857384/en/

    Michael Monahan, BeautyHealth (Photo: Business Wire)

    Michael Monahan, BeautyHealth (Photo: Business Wire)

    "Michael joins BeautyHealth as we bring to life our vision of a multi-brand ecosystem company, with a significant and untapped runway ahead. He is a highly regarded CFO with a strong blend of financial expertise and strategic vision who will continue to enhance our financial strategy, planning and reporting capabilities. I am looking forward to welcoming Michael to BeautyHealth's management team," said BeautyHealth President and CEO Andrew Stanleick.

    With nearly 15 years of experience as a public and private company CFO and more than 25 years of accounting and financial management experience, Monahan has a track record of driving financial and operational success in high-growth businesses. Most recently, he served as CFO of Casper Sleep (NYSE:CSPR), following its IPO. Prior, he served as CFO of Nutrisystem (NASDAQ:NTRI), quintupling its market cap and overseeing key M&A during his tenure.

    "BeautyHealth is an impressive category-creating company with a strong foundation and a lot of room for profitable growth," said Monahan. "I am delighted to partner with Andrew and the team to continue to build the business as a true multi-brand ecosystem."

    Commenting on Woo's departure, Stanleick said, "The Board and I are grateful for Liyuan's many meaningful contributions over the past several years. She has been a dynamic force during this transformative period for BeautyHealth, which included our journey to becoming a public company. We wish Liyuan every success in her future endeavors."

    About The Beauty Health Company

    The Beauty Health Company (NASDAQ:SKIN) is a global category-creating company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies, and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful community of estheticians, partners, and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types in more than 90 countries. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider/, and learn more at beautyhealth.com or LinkedIn.

    Forward-Looking Statements

    Certain statements made in this release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding The Beauty Health Company's strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

    These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside The Beauty Health Company's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

    Important factors that may affect actual results or outcomes include, among others: The Beauty Health Company's ability to manage growth; The Beauty Health Company's ability to execute its business plan; potential litigation involving The Beauty Health Company; changes in applicable laws or regulations; and the possibility that The Beauty Health Company may be adversely affected by other economic, business, and/or competitive factors. The Beauty Health Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230809857384/en/

    Get the next $SKIN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SKIN
    $CSPR

    CompanyDatePrice TargetRatingAnalyst
    The Beauty Health Company
    $SKIN
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    The Beauty Health Company
    $SKIN
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    The Beauty Health Company
    $SKIN
    11/14/2023Neutral → Underweight
    JP Morgan
    The Beauty Health Company
    $SKIN
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    The Beauty Health Company
    $SKIN
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    The Beauty Health Company
    $SKIN
    11/14/2023Buy → Hold
    The Benchmark Company
    The Beauty Health Company
    $SKIN
    11/14/2023Mkt Perform → Underperform
    Raymond James
    The Beauty Health Company
    $SKIN
    11/14/2023Outperform → Mkt Perform
    William Blair
    More analyst ratings

    $SKIN
    $CSPR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • BeautyHealth Surpasses 35,000 Hydrafacial Devices Worldwide Reflecting Growing Consumer Demand for Clinically Proven Skin Health Treatments

      LONG BEACH, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, recently achieved a major milestone with 35,000 Hydrafacial devices installed worldwide, reinforcing its market leadership in the hydradermabrasion category it pioneered. This accomplishment highlights the Hydrafacial treatment's continued global demand, fueled by strong brand awareness, and growing consumer preferences for non-invasive, results-driven skin health treatments. "With providers delivering approximately 5 million Hydrafacial treatments last year1, our position as one of the most in-demand professional skin health treatments is clear," said Beaut

      6/4/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company Announces Convertible Debt Refinancing

      LONG BEACH, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced that it entered into privately negotiated exchange agreements (the "Exchange Agreements") with certain holders (the "Exchanging Holders") of the Company's outstanding 1.25% convertible senior notes due 2026 (the "Existing Notes"). "Our refinancing marks a critical step in strengthening our financial position and extending a portion of our debt maturity, giving us greater flexibility to invest in long-term, profitable growth," said BeautyHealth Chief Executive Officer Marla Beck. "With a robust pipeline of innovation and bold brand initiatives,

      5/21/25 8:00:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Reports First Quarter 2025 Financial Results

      LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

      5/8/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    $CSPR
    Financials

    Live finance-specific insights

    See more
    • BeautyHealth Reports First Quarter 2025 Financial Results

      LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

      5/8/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth to Report First Quarter 2025 Financial Results on May 8, 2025

      LONG BEACH, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report first quarter 2025 financial results after market close on Thursday, May 8, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure InformationThe Beauty Health Company announces m

      4/29/25 4:00:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results

      LONG BEACH, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth"), home to flagship brand Hydrafacial, today announced financial results for the fourth quarter ended December 31, 2024 ("Q4 2024"). "In Q4 2024, we continued to strengthen our financial position, exceeding the high end of our guidance for both net sales and adjusted EBITDA," said CEO Marla Beck. "We increased consumable sales, expanded our gross margins and continued to reduce our operating expenses, delivering $9 million of adjusted EBITDA in the quarter. We now have over 34,000 global delivery systems serving our large provider base." "In 2025, we are focused on deepening

      3/12/25 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    $CSPR
    SEC Filings

    See more
    • The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - Beauty Health Co (0001818093) (Filer)

      5/27/25 5:19:53 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Beauty Health Co (0001818093) (Filer)

      5/21/25 4:13:53 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

      SCHEDULE 13G/A - Beauty Health Co (0001818093) (Subject)

      5/14/25 12:01:27 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    $CSPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Monahan Michael P. covered exercise/tax liability with 24,290 shares, decreasing direct ownership by 2% to 1,358,662 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      6/3/25 4:10:01 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • CSO and COO Lewis Sheri covered exercise/tax liability with 31,296 shares, decreasing direct ownership by 3% to 914,726 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      4/11/25 4:46:48 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • President and CEO Beck Marla Malcolm covered exercise/tax liability with 92,981 shares, decreasing direct ownership by 3% to 2,753,401 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      4/11/25 4:44:21 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    $CSPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

      4 - Beauty Health Co (0001818093) (Issuer)

      8/13/24 5:00:11 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    $CSPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • The Beauty Health Company downgraded by Jefferies with a new price target

      Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

      11/15/23 7:13:27 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company downgraded by JP Morgan

      JP Morgan downgraded The Beauty Health Company from Neutral to Underweight

      11/14/23 7:45:38 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • The Beauty Health Company downgraded by Canaccord Genuity with a new price target

      Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

      11/14/23 7:45:38 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    $CSPR
    Leadership Updates

    Live Leadership Updates

    See more
    • The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t

      10/15/24 4:10:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic

      4/9/24 4:10:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer

      The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company's permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company's Board of Directors, which she will continue to do going forward. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312423257/en/SKIN) (Photo: Business Wire)">Marla Beck, President and Chief Executive Officer, The Beauty Health Company (NASDAQ:SKIN) (Photo: Business Wire) "Over the past few months, the Board has undertaken

      3/12/24 4:05:00 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care

    $SKIN
    $CSPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 4:16:27 PM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 11:27:23 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

      SC 13G/A - Beauty Health Co (0001818093) (Subject)

      11/14/24 11:03:00 AM ET
      $SKIN
      Medical/Dental Instruments
      Health Care